|
1
|
Khans A, Thomas HC, Davidson BR and
Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 366:1303–1314.
2005. View Article : Google Scholar
|
|
2
|
Ortner MA and Dorta G: Technology insight:
Photodynamic therapy for cholangiocarcinoma. Nat Clin Pract
Gastroenterol Hepatol. 3:459–467. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang BY, Lu Y, Dong Q, Sun CD and Mu P:
Surgical treatment and prognostic analysis of 93 cases of hilar
cholangiocarcinoma. Am J Med Sci. 339:221–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jarnagin WR, Fong Y, DeMatteo RP, Gonen M,
Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D and Blumgart
LH: Staging, resectability and outcome in 225 patients with hilar
cholangiocarcinoma. Ann Surg. 234:507–517; discussion 517–519.
2001. View Article : Google Scholar
|
|
5
|
Patel T: Cholangiocarcinoma. Nat Clin
Pract Gastroenterol Hepatol. 3:33–42. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jarnagin WR and Shoup M: Surgical
management of cholangiocarcinoma. Semin Liver Dis. 24:189–199.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakamura H, Izumoto Y, Kambe H, Kuroda T,
Mori T, Kawamura K, Yamamoto H and Kishimoto T: Molecular cloning
of complementary DNA for a novel human hepatoma-derived growth
factor. Its homology with high mobility group-1 protein. J Biol
Chem. 269:25143–25149. 1994.PubMed/NCBI
|
|
8
|
Nakamura H, Kambe H, Egawa T, Kimura Y,
Ito H, Hayashi E, Yamamoto H, Sato J and Kishimotos: Partial
purification and characterization of human hepatoma-derived growth
factor. Clin Chim Acta. 183:273–284. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okuda Y, Nakamura H, Yoshida K, Enomoto H,
Uyama H, Hirotani T, Funamoto M, Ito H, Everett AD, Hada T, et al:
Hepatoma-derived growth factor induces tumorigenesis in vivo
through both direct angiogenic activity and induction of vascular
endothelial growth factor. Cancer Sci. 94:1034–1041. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Ren H, Yuan P, Lang W, Zhang L
and Mao L: Down-regulation of hepatoma-derived growth factor
inhibits anchorage-independent growth and invasion of non-small
cell lung cancer cells. Cancer Res. 66:18–23. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Everett AD, Narron JV, Stoops T, Nakamura
H and Tucker A: Hepatoma-derived growth factor is a pulmonary
endothelial cell-expressed angiogenic factor. Am J Physiol Lung
Cell Mol Physiol. 286:L1194–L1201. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Z, He Y, Wang S, Zhang A, Zhao P, Gao
C and Cao B: Various effects of hepatoma-derived growth factor on
cell growth, migration and invasion of breast cancer and prostate
cancer cells. Oncol Rep. 26:511–517. 2011.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Everett AD and Bushweller J: Hepatoma
derived growth factor is a nuclear targeted mitogen. Curr Drug
Targets. 4:367–371. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Everett AD, Stoops T and McNamara CA:
Nuclear targeting is required for hepatoma-derived growth
factor-stimulated mitogenesis in vascular smooth muscle cells. J
Biol Chem. 276:37564–37568. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kishima Y, Yamamoto H, Izumoto Y, Yoshida
K, Enomoto H, Yamamoto M, Kuroda T, Ito H, Yoshizaki K and Nakamura
H: Hepatoma-derived growth factor stimulates cell growth after
translocation to the nucleus by nuclear localization signals. J
Biol Chem. 277:10315–10322. 2002. View Article : Google Scholar
|
|
18
|
Zhou Z, Yamamoto Y, Sugai F, Yoshida K,
Kishima Y, Sumi H, Nakamura H and Sakodas: Hepatoma-derived growth
factor is a neurotrophic factor harbored in the nucleus. J Biol
Chem. 279:27320–27326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Everett AD, Lobe DR, Matsumura ME,
Nakamura H and McNamara CA: Hepatoma-derived growth factor
stimulates smooth muscle cell growth and is expressed in vascular
development. J Clin Invest. 105:567–575. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ooi BN, Mukhopadhyay A, Masilamani J, Do
DV, Lim CP, Cao XM, Lim IJ, Mao L, Ren HN, Nakamura H, et al:
Hepatoma-derived growth factor and its role in keloid pathogenesis.
J Cell Mol Med. 14:1328–1337. 2010. View Article : Google Scholar
|
|
21
|
Meng J, Xie W, Cao L, Hu C and Zhe Z:
shRNA targeting HDGF suppressed cell growth and invasion of
squamous cell lung cancer. Acta Biochim Biophys Sin (Shanghai).
42:52–57. 2010. View Article : Google Scholar
|
|
22
|
Tsang TY, Tang WY, Tsang WP, Co NN, Kongs
K and Kwok TT: Mechanistic study on growth suppression and
apoptosis induction by targeting hepatoma-derived growth factor in
human hepatocellular carcinoma HepG2 cells. Cell Physiol Biochem.
24:253–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu Y, Shen H, Yu H, Zhong F, Zhang Y,
Zhang C, Zhao J, Li H, Chen J, Liu Y, et al: Systematic proteomic
analysis of human hepotacellular carcinoma cells reveals molecular
pathways and networks involved in metastasis. Mol Biosyst.
7:1908–1916. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carson DA and Ribeiro JM: Apoptosis and
disease. Lancet. 341:1251–1254. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsang TY, Tang WY, Tsang WP, Co NN, Kongs
K and Kwok TT: Downregulation of hepatoma-derived growth factor
activates the Bad-mediated apoptotic pathway in human cancer cells.
Apoptosis. 13:1135–1147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ren H, Chu Z and Mao L: Antibodies
targeting hepatoma-derived growth factor as a novel strategy in
treating lung cancer. Mol Cancer Ther. 8:1106–1112. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao F, Dong W and Fan L: Apoptosis of
human colorectal carcinoma cells is induced by blocking
hepatoma-derived growth factor. Med Oncol. 27:1219–1226. 2010.
View Article : Google Scholar
|
|
28
|
Sahai E: Mechanisms of cancer cell
invasion. Curr Opin Genet Dev. 15:87–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valastyans and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar
|
|
30
|
Zhou Y, Zhou N, Fang W and Huo J:
Overexpressed HDGF as an independent prognostic factor is involved
in poor prognosis in Chinese patients with liver cancer. Diagn
Pathol. 5:582010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu YF, Zhao R, Guo S, Wang XQ, Lian PL,
Chen YG and Xu KS: Expression and clinical significance of
hepatoma-derived growth factor as a prognostic factor in human
hilar cholangio-carcinoma. Ann Surg Oncol. 18:872–879. 2011.
View Article : Google Scholar
|
|
32
|
Maeda K, Chung YS, Takatsukas, Ogawa Y,
Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y, et al:
Tumor angiogenesis as a predictor of recurrence in gastric
carcinoma. J Clin Oncol. 13:477–481. 1995.PubMed/NCBI
|
|
33
|
Oliver JA and Al-Awqati Q: An endothelial
growth factor involved in rat renal development. J Clin Invest.
102:1208–1219. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mao J, Xu Z, Fang Y, Wang H, Xu J, Ye J,
Zhengs and Zhu Y: Hepatoma-derived growth factor involved in the
carcinogenesis of gastric epithelial cells through promotion of
cell proliferation by Erk1/2 activation. Cancer Sci. 99:2120–2127.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee KH, Choi EY, Kim MK, Lee SH, Jang BI,
Kim TN, Kims W, Kims W, Songs K, Kim JR, et al: Hepatoma-derived
growth factor regulates the bad-mediated apoptotic pathway and
induction of vascular endothelial growth factor in stomach cancer
cells. Oncol Res. 19:67–76. 2010. View Article : Google Scholar
|
|
36
|
Ooi BN, Mukhopadhyay A, Masilamani J, Do
DV, Lim CP, Cao XM, Lim IJ, Mao L, Ren HN, Nakamura H, et al:
Hepatoma-derived growth factor and its role in keloid pathogenesis.
J Cell Mol Med. 14:1328–1337. 2010. View Article : Google Scholar
|
|
37
|
Okuda Y, Nakamura H, Yoshida K, Enomoto H,
Uyama H, Hirotani T, Funamoto M, Ito H, Everett AD, Hada T, et al:
Hepatoma-derived growth factor induces tumorigenesis in vivo
through both direct angiogenic activity and induction of vascular
endothelial growth factor. Cancer Sci. 94:1034–1041. 2003.
View Article : Google Scholar : PubMed/NCBI
|
